Uterine Adenosarcoma: Symptoms, Diagnosis and Support in the UK

Uterine adenosarcoma is a rare, low-grade malignant tumour that consists of both epithelial (lining) and mesenchymal (connective tissue) components. In the UK, it accounts for a very small percentage of uterine cancers, typically appearing as a polypoid mass within the womb. Unlike more common types of endometrial cancer, adenosarcomas are often diagnosed at a lower stage, but their rarity requires specialised clinical attention.

These tumours can occur at any age, though they are most frequently identified in postmenopausal women. While the exact cause remains unknown, researchers look into factors such as long-term oestrogen exposure and previous pelvic radiation. Because it often grows as a polyp, it can sometimes be mistaken for a benign uterine polyp during initial scans.

Recognising the symptoms of uterine adenosarcoma is vital for early intervention. Because the tumour often grows within the uterine cavity, it irritates the lining, leading to several physical signs:

• Abnormal Vaginal Bleeding: This is the primary symptom in over 90% of cases. It may manifest as bleeding after the menopause, heavy periods (menorrhagia), or spotting between menstrual cycles.
• Pelvic Pain or Pressure: A growing mass can cause a persistent dull ache in the lower abdomen or a feeling of fullness in the pelvic region.
• Vaginal Discharge: Some patients report an unusual, sometimes foul-smelling, watery or bloody discharge.
• Visible Polyps: Occasionally, the tumour grows large enough to protrude through the cervix, which may be felt during a routine smear test or pelvic examination.

Initial Consultation

If you present with abnormal bleeding, a GP will follow NICE (National Institute for Health and Care Excellence) guidelines for suspected cancer. This usually involves an urgent referral to a gynaecologist, often under the 'two-week wait' rule in the NHS.

Diagnostic Tests

To confirm a diagnosis of uterine adenosarcoma, specialists typically perform:

• Transvaginal Ultrasound: To look for thickening of the womb lining or the presence of a mass.
• Hysteroscopy: A thin telescope is inserted into the womb to allow the doctor to see any growths directly.
• Endometrial Biopsy: A small sample of tissue is taken for laboratory analysis. This is the only definitive way to distinguish between a benign polyp and an adenosarcoma.
• MRI or CT Scans: These are used to determine if the tumour has spread to nearby tissues or lymph nodes.

The standard treatment for uterine adenosarcoma is surgery. In most cases, a total hysterectomy (removal of the womb and cervix) along with bilateral salpingo-oophorectomy (removal of the fallopian tubes and ovaries) is recommended. This reduces the risk of recurrence, as these tumours can be sensitive to hormones produced by the ovaries.

For younger women wishing to preserve fertility, conservative management is rarely advised due to the risk of malignancy, but it may be discussed in very specific, low-grade cases at specialist centres. Radiotherapy or chemotherapy is not typically the first line of treatment for low-grade adenosarcoma but may be used if the tumour has 'sarcomatous overgrowth,' which indicates a more aggressive form of the disease.

When you experience worrying symptoms like pelvic pain or intermenstrual spotting, you may feel anxious about waiting for a local GP appointment. You can speak to a GP online to discuss your symptoms in a calm, confidential environment. An online doctor can provide an initial assessment, explain the potential causes of your symptoms, and advise you on the next steps.

If your symptoms warrant further investigation, an online GP can issue a referral letter to a private specialist or advise you on how to navigate the NHS urgent referral system. Early discussion is always better than waiting, especially with symptoms involving the reproductive system.

Being diagnosed with a rare condition like uterine adenosarcoma can be overwhelming. In the UK, patients are usually managed by a Multidisciplinary Team (MDT), including oncologists, surgeons, and specialist nurses. Support groups and charities like Target Ovarian Cancer (which often covers broader gynaecological cancers) and Sarcoma UK can provide valuable resources and peer support to help patients through their recovery journey.